Minocycline hydrochloride extended release - Dr Reddy's Laboratories

Drug Profile

Minocycline hydrochloride extended release - Dr Reddy's Laboratories

Alternative Names: DFD 10; DFD-29; Minocycline HCl extended release - Dr. Reddy's Laboratories/Promius Pharma; Minocycline hydrochloride extended release - Dr. Reddy's Laboratories/Promius Pharma; MINOLIRA

Latest Information Update: 16 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dr Reddys Laboratories
  • Developer Dr Reddys Laboratories; Promius Pharma
  • Class Amides; Antibacterials; Dimethylamines; Neuroprotectants; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Acne vulgaris
  • Phase II Rosacea

Most Recent Events

  • 08 May 2017 Registered for Acne vulgaris in USA (PO)
  • 14 Feb 2017 Chemical structure information added
  • 03 Jan 2017 Phase-II clinical trials in Rosacea in Germany (PO) (EudraCT2016-003197-41)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top